Search alternatives:
significant linear » significant clinical (Expand Search), significant gender (Expand Search), significant level (Expand Search)
larger decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
significant linear » significant clinical (Expand Search), significant gender (Expand Search), significant level (Expand Search)
larger decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
-
1621
-
1622
-
1623
-
1624
Sociodemographic characteristics of the sample.
Published 2025“…Statistical analyses included descriptive statistics, Spearman’s correlation, and multiple linear regression. Participants demonstrated significantly higher awareness of scientifically established cancer causes (70.7%) compared to mythical ones (10.2%). …”
-
1625
-
1626
Baseline characteristics of the study sample<sup>β</sup>μ.
Published 2024“…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …”
-
1627
The flow diagram of the study (CONSORT, 2010).
Published 2024“…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …”
-
1628
-
1629
-
1630
-
1631
-
1632
-
1633
-
1634
-
1635
-
1636
-
1637
-
1638
-
1639
-
1640